Potential Beneficial Effect of Antidiabetic Medications COPD Exacerbations
Duration-dependent beneficial effects of metformin, sulfonylurea, and thiazolidinedione use on COPD exacerbation have been observed in patients with COPD and diabetes.
Chronic Obstructive Pulmonary Disease
Reduced All-Cause Mortality in COPD With Budesonide/ Glycopyrrolate/ Formoterol
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate may reduce the risk of death compared with glycopyrrolate/formoterol fumarate in patients with COPD.
Inhaled Corticosteroid Therapy May Reduce Lung Function Decline in COPD
The adjusted rate of decline in predose trough FEV1 during 52 weeks in the
Researchers used a substudy of the Phase 3 ETHOS study to evaluate lung function decline in patients with inhaled corticosteroid-containing therapies vs glycopyrrolate/formoterol fumarate metered dose inhaler.
Revefenacin Plus Formoterol Via Nebulization Improves Lung Function Response in COPD
Once-daily revefenacin when administered via a jet nebulizer with formoterol was well tolerated and associated with greater lung function response compared with formoterol alone in patients with COPD.
COVID-19 With COPD: Fewer Hospitalizations, But Greater Mortality
Chronic obstructive pulmonary disease may be associated with higher rates of mortality in patients with coronavirus disease 2019.
HRRP Implementation Reduced 30-Day All-Cause Readmission Rates in COPD
Implementation of the Hospital Readmission Reduction Program was associated with a decrease in 30-day readmissions in patients with COPD following their hospital discharge.
Acute COPD Exacerbation Frequency May Not Be Accurate Guide for Treatment
The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype.
Electronic Communication From Pulmonologist to PCP Beneficial in COPD Care
Preemptive, patient-specific electronic messages from pulmonologists to primary care physicians improved guideline concordant care in COPD.
Guideline Details Pharmacologic Management of COPD
In an American Thoracic Society clinical practice guideline, recommendations are presented for the pharmacologic management of patients with chronic obstructive pulmonary disease (COPD) complaining of exercise intolerance or dyspnea.
Environmental Fungal Sensitization Associated With Worse Outcomes in COPD
Sensitization to environmental fungi was associated with poorer outcomes in patients with COPD.
-
Loading...
-
Loading...
Next post in COPD Information Center
